ArcherDX has developed a number of cancer precision medical tests to address the limitations of cancer detection. Using advanced AMP (Anchored Multiplex PCR) technology, it can accurately quantify and detect unknown fusion mutations. The design of the freeze-dried reagent greatly simplifies the operation steps. ArcherDX has a powerful NGS analysis software and a user-friendly operation interface, that can do the cancer reports in a short time.
The current ArcherDX RUO product portfolio includes: